Clinical trials: Parotid Neoplasms

Parotid Neoplasm, Thyroid Neoplasms

Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

• Completed
• Age: 18 years and older
• Phase 1/2
• Injection or infusion
• Results posted

Bevonescein to Highlight Nerves in Patients Undergoing Head \& Neck Surgery

Conditions

Parotid Neoplasm, Thyroid Neoplasms, Head and Neck Neoplasms, Surgery

Trial name

NCT04420689

Testing

Bevonescein

Where

3 sites in United States

Volunteers

27 people

Sponsor

Alume Biosciences, Inc.